Drugs for gastro-intestinal, respiratory and hormonal troubles
14.3%
14.7%
16.5%
Anti-infectious drugs
50.8%
46.6%
45.1%
Anti-inflammatory drugs
15.1%
16.0%
10.7%
Other therapeutic groups
17.5%
8.6%
8.3%
Table 3: Repartition (%) of the generic oral tablet and capsule applications for registration, in function to the continent of manufacturing and the therapeutic group.
